Retraction Note to: Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFκB pathway in streptozocin-induced diabetic rats (Archives of Pharmacal Research, (2012), 35, 5, (877-886), 10.1007/s12272-012-0513-0);Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFκB pathway in streptozocin-induced diabetic rats

Archives of Pharmacal Research

Volumn 35, Issue 5, 2012, Pages 877-886

  Xiang, Min ^a   Wang, Jianmei ^a   Zhang, Yaqin ^a   Ling, Jing ^a   Xu, Xiaoyue ^b  

^a Suzhou Health College   (China)

^b Henan Provincial Institute for Food and Drug Control   (China)

Author keywords

NF B; Oxidative stress; P22phox; RAGE; Ursolic acid; Vascular complications

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ARCH; AORTA INJURY; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

EID: 84862859846     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-020-01262-x     Document Type: Erratum

References (45)

1. Ahmed, N., Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Pract., 67, 3-21 (2005).
2. Avendano, G. F., Agarwal, R. K., Bashey, R. I., Lyons, M. M., Soni, B. J., Jyothirmayi, G. N., and Regan, T. J., Effects of glucose intolerance on myocardial function and collagenlinked glycation. Diabetes, 48, 1443-1447 (1999).
3. Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., and De Caterina, R., Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation, 105, 816-822 (2002).
4. Bucala, R., Mitchell, R., Arnold, K., Innerarity, T., Vlassara, H., and Cerami, A., Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J. Biol. Chem., 270, 10828-10832 (1995).
5. Chandra, D., Jackson, E. B., Ramana, K. V., Kelley, R., Srivastava, S. K., and Bhatnagar, A., Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes, 51, 3095-3101 (2002).
6. Gao, X., Zhang, H., Schmidt, A. M., and Zhang, C., AGE/ RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol., 295, H491-H498 (2008).
7. Goldin, A., Beckman, J. A., Schmidt, A. M., and Creager, M. A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 114, 597-605 (2006).
8. Guha, M., Bai, W., Nadler, J. L., and Natarajan, R., Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem., 275, 17728-17739 (2000).
9. Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., and Channon, K. M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation, 105, 1656-1662 (2002).
10. Ha, H., Hwang, I. A., Park, J. H., and Lee, H. B., Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res. Clin. Pract., 82 Suppl 1, S42-S45 (2008).
11. Hudson, B. I., Bucciarelli, L. G., Wendt, T., Sakaguchi, T., Lalla, E., Qu, W., Lu, Y., Lee, L., Stern, D. M., Naka, Y., Ramasamy, R., Yan, S. D., Yan, S. F., D'Agati, V., and Schmidt, A. M., Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch. Biochem. Biophys., 419, 80-88 (2003).
12. Figarola, J. L., Shanmugam, N., Natarajan, R., and Rahbar, S., Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes, 56, 647-655 (2007).
13. Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., 4th, Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., and Griendling, K. K., p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res., 80, 45-51 (1997).
14. Jandeleit-Dahm, K. and Cooper, M. E., The role of AGEs in cardiovascular disease.. The role of AGES in cardiovascular diseases. Curr. Pharm. Des., 14, 979-986 (2008).
15. Jang, S. M., Yee, S. T., Choi, J., Choi, M. S., Do, G. M., Jeon, S. M., Yeo, J., Kim, M. J., Seo, K. I., and Lee, M. K., Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin- induced diabetic mice fed a high-fat diet. Int. Immunopharmacol., 9, 113-119 (2009).
16. Jun, C., Jun, L., Yanchun, G., Luyong, Z., Yiwei, H., and HongBin, S., Synthesis and biological evaluation of ursolic acid derivatives as novel inhibitors of glycogen phosphorylase. Journal of China Pharmaceutical University, 37, 397-402 (2006).
17. Jung, S. H., Ha, Y. J., Shim, E. K., Choi, S. Y., Jin, J. L., Yun-Choi, H. S., and Lee, J. R., Insulin-mimetic and insulinsensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem. J., 403, 243-250 (2007).
18. Kim, J., Jang, D. S., Kim, H., and Kim, J. S., Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta. Arch. Pharm. Res., 32, 983-987 (2009).
19. Kim, Y. K., Lee, M. S., Son, S. M., Kim, I. J., Lee, W. S., Rhim, B. Y., Hong, K. W., and Kim, C. D., Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes, 51, 522-527 (2002).
20. Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., Sakurai, S., Yamamoto, Y., Yonekura, H., Watanabe, T., Yamamoto, H., and Nishizawa, Y., Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 25, 2587-2593 (2005).
21. Lassègue, B. and Clempus, R. E., Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, R277-R297 (2003).
22. Lee, M. S. and Thuong, P. T., Stimulation of glucose uptake by triterpenoids from Weigela subsessilis. Phytother. Res., 24, 49-53 (2010).
23. Li, J. M. and Shah, A. M., Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem., 277, 19952-19960 (2002).
24. Li, J. and Schmidt, A. M., Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem., 272, 16498-16506 (1997).
25. Liu, J., Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol., 49, 57-68 (1995).
26. Mukherjee, T. K., Mukhopadhyay, S., and Hoidal, J. R., The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim. Biophys. Acta, 1744, 213-223 (2005).
27. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., and Shaw, A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem., 267, 14998-15004 (1992).
28. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I., and Brownlee, M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404, 787-790 (2000).
29. Oh, C. J., Kil, I. S., Park, C. I., Yang, C. H., and Park, J. W., Ursolic acid regulates high glucose-induced apoptosis. Free Radic. Res., 41, 638-644 (2007).
30. Ovesná, Z., Vachálková, A., Horváthová , K., and Tóthová, D., Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma, 51, 327-333 (2004).
31. Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Jr., Chow, W. S., Stern, D., and Schmidt, A. M., Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med., 4, 1025-1031 (1998).
32. Saravanan, R. and Pugalendi, V., Impact of ursolic acid on chronic ethanol-induced oxidative stress in the rat heart. Pharmacol. Rep., 58, 41-47 (2006).
33. Selvin, E., Coresh, J., Golden, S. H., Boland, L. L., Brancati, F. L., and Steffes, M. W., Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care, 28, 1965-1973 (2005).
34. Shishodia, S., Majumdar, S., Banerjee, S., and Aggarwal, B. B., Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res., 63, 4375-4383 (2003).
35. Soro-Paavonen, A., Watson, A. M., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., Thomas, M., Forbes, J. M., Nawroth, P. P., Bierhaus, A., Cooper, M. E., and Jandeleit-Dahm, K. A., Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes, 57, 2461-2469 (2008).
36. Somova, L. O., Nadar, A., Rammanan, P., and Shode, F. O., Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine, 10, 115-121 (2003).
37. Steinkamp-Fenske, K., Bollinger, L., Völler, N., Xu, H., Yao, Y., Bauer, R., Förstermann, U., and Li, H., Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells. Atherosclerosis, 195, e104-e111 (2007).
38. Tanji, N., Markowitz, G. S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D., Schmidt, A. M., and D'Agati, V. D., Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol., 11, 1656-1666 (2000).
39. Tsai, S. J. and Yin, M. C., Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells. J. Food Sci., 73, H174-H178 (2008).
40. Wang, Z., Li, D. D., Liang, Y. Y., Wang, D. S., and Cai, N. S., Activation of astrocytes by advanced glycation end products: cytokines induction and nitric oxide release. Acta Pharmacol. Sin., 23, 974-980 (2002).
41. Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., and Wautier, J. L., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab., 280, E685-E694 (2001).
42. Yin, M. C. and Chan, K. C., Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J. Agric. Food Chem., 55, 7177-7181 (2007).
43. Ushio-Fukai, M., Zafari, A. M., Fukui, T., Ishizaka, N., and Griendling, K. K., p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem., 271, 23317-23321 (1996).
44. Zalba, G., Beaumont, F. J., San José, G., Fortuño, A., Fortuño, M. A., Etayo, J. C., and Díez, J., Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 35, 1055-1061 (2000).
45. Zhou, Y., Li, J. S., Zhang, X., Wu, Y. J., Huang, K., and Zheng, L., Ursolic acid inhibits early lesions of diabetic nephropathy. Int. J. Mol. Med., 26, 565-570 (2010).